16:54 - 16.07.2025

---

July 16, Fineko/abc.az. Johnson & Johnson shares rose 1.6% after the publication of the quarterly report: profit and revenue exceeded expectations due to increased sales of drugs for cancer and cardiovascular diseases.

ABC.AZ reports that company's sales grew by 5.8% up to $23.74 billion, and adjusted earnings per share amounted to $2.77 against projected $2.68. The company raised its annual profit and revenue forecast. Since the beginning of 2025, J&J shares have gained 7.3%.